1. Home
  2. FFIC vs ALT Comparison

FFIC vs ALT Comparison

Compare FFIC & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFIC
  • ALT
  • Stock Information
  • Founded
  • FFIC 1929
  • ALT 1997
  • Country
  • FFIC United States
  • ALT United States
  • Employees
  • FFIC N/A
  • ALT N/A
  • Industry
  • FFIC Major Banks
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FFIC Finance
  • ALT Health Care
  • Exchange
  • FFIC Nasdaq
  • ALT Nasdaq
  • Market Cap
  • FFIC 408.4M
  • ALT 333.6M
  • IPO Year
  • FFIC 1995
  • ALT N/A
  • Fundamental
  • Price
  • FFIC $13.22
  • ALT $4.04
  • Analyst Decision
  • FFIC
  • ALT Strong Buy
  • Analyst Count
  • FFIC 0
  • ALT 7
  • Target Price
  • FFIC N/A
  • ALT $16.50
  • AVG Volume (30 Days)
  • FFIC 227.3K
  • ALT 2.8M
  • Earning Date
  • FFIC 10-29-2025
  • ALT 11-11-2025
  • Dividend Yield
  • FFIC 6.68%
  • ALT N/A
  • EPS Growth
  • FFIC N/A
  • ALT N/A
  • EPS
  • FFIC N/A
  • ALT N/A
  • Revenue
  • FFIC $137,137,000.00
  • ALT $20,000.00
  • Revenue This Year
  • FFIC $113.87
  • ALT N/A
  • Revenue Next Year
  • FFIC $5.75
  • ALT N/A
  • P/E Ratio
  • FFIC N/A
  • ALT N/A
  • Revenue Growth
  • FFIC N/A
  • ALT N/A
  • 52 Week Low
  • FFIC $10.65
  • ALT $2.90
  • 52 Week High
  • FFIC $18.59
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • FFIC 47.09
  • ALT 56.07
  • Support Level
  • FFIC $12.46
  • ALT $3.79
  • Resistance Level
  • FFIC $13.42
  • ALT $4.15
  • Average True Range (ATR)
  • FFIC 0.45
  • ALT 0.19
  • MACD
  • FFIC -0.14
  • ALT 0.00
  • Stochastic Oscillator
  • FFIC 43.90
  • ALT 63.31

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: